Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel. more
Time Frame | NSPR | Sector | S&P500 |
---|---|---|---|
1-Week Return | 1.72% | -0.94% | -2.6% |
1-Month Return | 0.34% | -5.08% | -1.08% |
3-Month Return | 6.88% | -10.62% | 3.45% |
6-Month Return | 16.14% | -6.18% | 8.57% |
1-Year Return | 27.71% | 1.98% | 24.3% |
3-Year Return | -9.79% | -0.93% | 25.58% |
5-Year Return | -79.51% | 33.84% | 84.07% |
10-Year Return | -100% | 102.52% | 185.12% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 3.72M | 2.48M | 4.50M | 5.17M | 6.21M | [{"date":"2019-12-31","value":59.97,"profit":true},{"date":"2020-12-31","value":40.05,"profit":true},{"date":"2021-12-31","value":72.44,"profit":true},{"date":"2022-12-31","value":83.34,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 2.96M | 2.40M | 3.74M | 4.05M | 4.40M | [{"date":"2019-12-31","value":67.42,"profit":true},{"date":"2020-12-31","value":54.62,"profit":true},{"date":"2021-12-31","value":85.06,"profit":true},{"date":"2022-12-31","value":92.18,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 756.00K | 83.00K | 754.00K | 1.12M | 1.81M | [{"date":"2019-12-31","value":41.84,"profit":true},{"date":"2020-12-31","value":4.59,"profit":true},{"date":"2021-12-31","value":41.73,"profit":true},{"date":"2022-12-31","value":61.82,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 20.32% | 3.34% | 16.77% | 21.60% | 29.12% | [{"date":"2019-12-31","value":69.77,"profit":true},{"date":"2020-12-31","value":11.47,"profit":true},{"date":"2021-12-31","value":57.6,"profit":true},{"date":"2022-12-31","value":74.18,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Expenses | 10.57M | 10.46M | 15.47M | 19.83M | 22.95M | [{"date":"2019-12-31","value":46.07,"profit":true},{"date":"2020-12-31","value":45.59,"profit":true},{"date":"2021-12-31","value":67.41,"profit":true},{"date":"2022-12-31","value":86.41,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (9.82M) | (10.38M) | (14.72M) | (18.71M) | (21.14M) | [{"date":"2019-12-31","value":-981600000,"profit":false},{"date":"2020-12-31","value":-1038000000,"profit":false},{"date":"2021-12-31","value":-1471600000,"profit":false},{"date":"2022-12-31","value":-1871300000,"profit":false},{"date":"2023-12-31","value":-2114300000,"profit":false}] |
Total Non-Operating Income/Expense | (400.00K) | (320.00K) | (314.00K) | 500.00K | 2.58M | [{"date":"2019-12-31","value":-15.48,"profit":false},{"date":"2020-12-31","value":-12.38,"profit":false},{"date":"2021-12-31","value":-12.15,"profit":false},{"date":"2022-12-31","value":19.35,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (10.02M) | (10.54M) | (14.87M) | (18.46M) | (19.85M) | [{"date":"2019-12-31","value":-1001600000,"profit":false},{"date":"2020-12-31","value":-1054000000,"profit":false},{"date":"2021-12-31","value":-1487300000,"profit":false},{"date":"2022-12-31","value":-1846300000,"profit":false},{"date":"2023-12-31","value":-1985100000,"profit":false}] |
Income Taxes | 24.00K | 4.00K | 45.00K | 28.00K | 65.00K | [{"date":"2019-12-31","value":36.92,"profit":true},{"date":"2020-12-31","value":6.15,"profit":true},{"date":"2021-12-31","value":69.23,"profit":true},{"date":"2022-12-31","value":43.08,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | (10.04M) | (10.54M) | (14.92M) | (18.49M) | (19.92M) | [{"date":"2019-12-31","value":-1004000000,"profit":false},{"date":"2020-12-31","value":-1054400000,"profit":false},{"date":"2021-12-31","value":-1491800000,"profit":false},{"date":"2022-12-31","value":-1849100000,"profit":false},{"date":"2023-12-31","value":-1991600000,"profit":false}] |
Income From Continuous Operations | (10.04M) | (10.54M) | (14.92M) | (18.49M) | (19.92M) | [{"date":"2019-12-31","value":-1004000000,"profit":false},{"date":"2020-12-31","value":-1054400000,"profit":false},{"date":"2021-12-31","value":-1491800000,"profit":false},{"date":"2022-12-31","value":-1849100000,"profit":false},{"date":"2023-12-31","value":-1991600000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (10.04M) | (10.54M) | (14.92M) | (18.49M) | (19.92M) | [{"date":"2019-12-31","value":-1004000000,"profit":false},{"date":"2020-12-31","value":-1054400000,"profit":false},{"date":"2021-12-31","value":-1491800000,"profit":false},{"date":"2022-12-31","value":-1849100000,"profit":false},{"date":"2023-12-31","value":-1991600000,"profit":false}] |
EPS (Diluted) | (108.60) | (11.55) | (2.05) | (2.34) | (1.08) | [{"date":"2019-12-31","value":-10860,"profit":false},{"date":"2020-12-31","value":-1155,"profit":false},{"date":"2021-12-31","value":-205,"profit":false},{"date":"2022-12-31","value":-234,"profit":false},{"date":"2023-12-31","value":-108,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
NSPR | |
---|---|
Cash Ratio | 5.56 |
Current Ratio | 6.39 |
Quick Ratio | 6.05 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
NSPR | |
---|---|
ROA (LTM) | -37.24% |
ROE (LTM) | -66.75% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
NSPR | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.18 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.82 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
NSPR | |
---|---|
Trailing PE | NM |
Forward PE | 11.70 |
P/S (TTM) | 11.28 |
P/B | 1.86 |
Price/FCF | NM |
EV/R | 5.54 |
EV/Ebitda | 0.52 |
PEG | NM |
InspireMD Inc (NSPR) share price today is $2.95
Yes, Indians can buy shares of InspireMD Inc (NSPR) on Vested. To buy InspireMD Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NSPR stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of InspireMD Inc (NSPR) via the Vested app. You can start investing in InspireMD Inc (NSPR) with a minimum investment of $1.
You can invest in shares of InspireMD Inc (NSPR) via Vested in three simple steps:
The 52-week high price of InspireMD Inc (NSPR) is $3.42. The 52-week low price of InspireMD Inc (NSPR) is $1.81.
The price-to-earnings (P/E) ratio of InspireMD Inc (NSPR) is
The price-to-book (P/B) ratio of InspireMD Inc (NSPR) is 1.86
The dividend yield of InspireMD Inc (NSPR) is 0.00%
The market capitalization of InspireMD Inc (NSPR) is $78.25M
The stock symbol (or ticker) of InspireMD Inc is NSPR